News


Sygnature Discovery to Partner with UCL School of Pharmacy for £1M Pancreatic Cancer Research Project

3rd August 2017 – Nottingham, UK – Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, has been appointed by UCL to lead an optimisation project targeting pancreatic cancer. The project is based upon research done by Professor Stephen Neidle’s group in the UCL School of Pharmacy, in collaboration with […]

Sygnature Discovery presented with a Queen’s Award for Enterprise 2017 at VIP ceremony to confer the Grant of Appointment

25th July 2017 – Nottingham, UK – Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, has today been presented with one of the UK’s most prestigious business awards – the Queen’s Award for Enterprise – at a special VIP ceremony. Founder and CEO of Sygnature Discovery, Dr Simon Hirst, […]

STOP PRESS: Sygnature Discovery named as Finalist in OBN Awards 2017 Best CRO category

26th July 2017 – Nottingham, UK – Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, is pleased to announce that it is a finalist in the OBN Awards 2017 Best Contract Research Organisation category. The OBN Awards 2017, now in their 9th year, celebrate innovation and outstanding achievement across […]


View All News
Conferences

Meet Sygnature at the following Conferences throughout 2015:



Biotech Showcase/JP Morgan

9-11th January 2017
San Francisco USA


RSC OrgSyn 50

27-28 February 2017
Manchester UK


Proventa Medicinal Chemistry Strategy

14th March 2017
London



View All Conferences
Media

Sygnature Discovery



View All Media
Publications

KINASE INHIBITORS, FRICKEL, Fritz-Frieder

KINASE INHIBITORS, FRICKEL, Fritz-Frieder; FYFE, Matthew, Colin, Thor; MEGHANI, Premji; THOM, Stephen, Malcolm; (RespiVert Ltd. and TopiVert Ltd.), WO 2014076484 (2014).


PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne

PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne; KING-UNDERWOOD, John; LONGSHAW, Alistair Ian; MURRAY, Peter John; ONIONS, Stuart Thomas; TADDEI, David Michael Adrien; WILLIAMS, Jonathan Gareth; ITO, Kazuhiro; CHARRON, Catherine Elisabeth; (GB) (RespiVert Ltd. and TopiVert Ltd.), WO 2014033448 (2014).


KINASE INHIBITORS, FYFE, Matthew Colin Thor

KINASE INHIBITORS, FYFE, Matthew Colin Thor; MEGHANI, Premji; STENT, Matthew Alexander Henry; THOM, Stephen Malcolm; WALSHE, Claire Anne; (RespiVert Ltd. and TopiVert Ltd.), WO 2014033447 (2014).



View All Publications
Search


Get in Touch


Vacancies
  • Posted: May 3, 2017
    Senior Scientists in DMPK

  • Posted: March 3, 2017
    Analytical Chemist


  • See more
    Latest news
  • Sygnature Discovery to Partner with UCL School of Pharmacy for £1M Pancreatic Cancer Research Project
  • Copyright © 2017 Sygnature Discovery

    Website built by AtomicMedia - Design by Freestyle.